138 related articles for article (PubMed ID: 24443365)
1. The role of melanocortin 1 receptor in cutaneous malignant melanoma: along the mitogen-activated protein kinase pathway.
Steck MB
Biol Res Nurs; 2014 Oct; 16(4):421-8. PubMed ID: 24443365
[TBL] [Abstract][Full Text] [Related]
2. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
[TBL] [Abstract][Full Text] [Related]
3. [Clinico-genetic aspects of cutaneous melanoma. I. Incidence, familial study, genetic heterogeneity].
Gar'kavtseva RF; Sitnikova TS; Kazubskaia TP; Demidov LV; Kharkevich GIu
Genetika; 1995 Nov; 31(11):1557-61. PubMed ID: 8666222
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP (cAMP) signaling in melanocytes and melanoma.
Rodríguez CI; Setaluri V
Arch Biochem Biophys; 2014 Dec; 563():22-7. PubMed ID: 25017568
[TBL] [Abstract][Full Text] [Related]
5. Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients.
Metzelaar-Blok JA; ter Huurne JA; Hurks HM; Keunen JE; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1951-4. PubMed ID: 11481256
[TBL] [Abstract][Full Text] [Related]
6. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
7. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects.
Kosiniak-Kamysz A; Marczakiewicz-Lustig A; Marcińska M; Skowron M; Wojas-Pelc A; Pośpiech E; Branicki W
Melanoma Res; 2014 Aug; 24(4):388-96. PubMed ID: 24926819
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
[TBL] [Abstract][Full Text] [Related]
10. The Y152X MC1R gene mutation: occurrence in ethnically diverse Jewish malignant melanoma patients.
Galore G; Azizi E; Scope A; Pavlotsky F; Yakobson E; Friedman E
Melanoma Res; 2007 Apr; 17(2):105-8. PubMed ID: 17496785
[TBL] [Abstract][Full Text] [Related]
11. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
[TBL] [Abstract][Full Text] [Related]
12. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
Quint KD; van der Rhee JI; Gruis NA; Ter Huurne JA; Wolterbeek R; van der Stoep N; Bergman W; Kukutsch NA
Acta Derm Venereol; 2012 Nov; 92(6):587-92. PubMed ID: 22965007
[TBL] [Abstract][Full Text] [Related]
14. Comparison between familial and nonfamilial melanoma in France.
Grange F; Chompret A; Guilloud-Bataille M; Guillaume JC; Margulis A; Prade M; Demenais F; Avril MF
Arch Dermatol; 1995 Oct; 131(10):1154-9. PubMed ID: 7574832
[TBL] [Abstract][Full Text] [Related]
15. [Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms].
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012; 103(1):44-50. PubMed ID: 21737053
[TBL] [Abstract][Full Text] [Related]
16. [The sun and malignant melanoma].
Garbe C
Hautarzt; 1992 May; 43(5):251-7. PubMed ID: 1612913
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of patients with cutaneous melanoma according to variants in the melanocortin 1 receptor gene.
Peña-Vilabelda MM; García-Casado Z; Requena C; Traves V; López-Guerrero JA; Guillén C; Kumar R; Nagore E
Actas Dermosifiliogr; 2014 Mar; 105(2):159-71. PubMed ID: 24238329
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous malignant melanoma and Parkinson disease: Common pathways?
Inzelberg R; Flash S; Friedman E; Azizi E
Ann Neurol; 2016 Dec; 80(6):811-820. PubMed ID: 27761938
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
20. Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma.
Panka DJ; Atkins MB; Mier JW
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2371s-2375s. PubMed ID: 16609061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
